Rome, 19 December 2025 - The Pontine Science and Technology Park - Technoscience took part in the ceremony for laying of the foundation stone of the new Rome Technopole Headquarters, a symbolic and strategic event for the development of theItalian innovation ecosystem.
The ceremony, held in the area of Pietralata in Rome, marked the official start of work on the future headquarters of Rome Technopole, an advanced research, training and technology-transfer infrastructure created with funding from the NRRP - Mission 4, with the aim of creating an integrated hub that fosters collaboration among universities, institutions, research organisations and companies.
Technoscience at the Heart of Governance
Technoscience is represented on the Steering Committee of Rome Technopole and took part in the ceremony through three institutional representatives:
- il Director General of the Park,
- il Head of the Biotech Competence Centre,
- il Business Development Manager.
Participation reflects Technoscience's active role in promotingbiotech innovation, applied research and technology transfer between research and business.
Institutional authorities and partners in attendance
The foundation-stone ceremony was attended by important authorities and institutional leaders representing Italy's public and academic system involved in the project:
- Antonella Polimeni - Rector of Sapienza University of Rome and President of the Rome Technopole Foundation
- Francesco Rocca - President of the Lazio Region
- Roberto Gualtieri - Mayor of Rome
- Roberta Angelilli - Vice-President of the Lazio Region
- Giuseppe Biazzo - President of Unindustria
- Marco Mancini - Secretary General of the Ministry of University and Research
- Lorenzo Tagliavanti - President of the Rome Chamber of Commerce
Tags
A Research and Innovation Hub for the Future
The Rome Technopole was established with the mission of becoming a centre of excellence for research, advanced training and technology transfer, integrating spaces for laboratories, teaching, startup incubation and public-private collaboration.
The new facility, designed according to criteria of environmental sustainability and technological innovation, is conceived as a dynamic and inclusive hub designed to attract talent, startups, companies and investment, with the aim of strengthening the competitiveness of Italy's scientific and industrial system and helping to create new highly skilled employment.
Technoscience’s Role in the Innovation Ecosystem
Technoscience's participation in the laying of the foundation stone of Rome Technopole strengthens the Park's positioning as a strategic partner in governance of major national innovation projects. Through its contribution to strategic guidance activities, Technoscience reaffirms its commitment to promoting applied research, the adoption of emerging technologies and stronger links between academia and industry, with a particular focus on biotech.
👉 For more details about the project Rome Technopole, visit the official website: rometechnopole.it.
How we turn ideas into biotech projects
Would you like to understand how we could work together on complex biotech projects, such as the one on glioblastoma? Below is a selection of in-depth pages on biopharmaceutical pipelines, biobanks, data management and AI, telemedicine, precision cardiology and TRL pathways. They are the starting point for turning a good idea into an operational pathway, from the initial concept through to clinical validation and market entry.
Careers & Skills
Industry & Technology Transfer
GREEN & AGRI-BIOTECH
Biopharmaceuticals & Therapies
Biotechnology for Health
Frequently Asked Questions
Choose Technoscience!
To rapidly assess a project in biotech and translational medicine - from oncology and neuroscience to precision cardiology and telemedicine - we ask for: a clear clinical or industrial question, the available evidence (including negative findings), access to data and samples where applicable, a draft protocol (including ethical aspects), and hypotheses on biomarkers and endpoints. In return, we offer technical and scientific due diligence, the design of a credible TRL pathway and, where appropriate, support with regulatory strategy, validation and scalability.
Biotech FAQ
The questions you ask us most often
It is an approach that defines the the actual biology of the disease (tissues, markers and omics profiles where indicated) and links it to diagnostic and therapeutic decisions diagnostic and therapeutic personalised. It does not stop at generic classifications or guidelines applied wholesale: it builds a individual pathway measurable through robust clinical endpoints.
An enabling role. The biobanks ensure traceable and comparable samples; the omics broaden the understanding of the underlying mechanisms (inflammatory, metabolic and genetic). When integrated with rigorous protocols and real-world data, make reproducible the evidence and accelerate translation towards clinical trials or clinical adoption.
